JP2024504927A5 - - Google Patents
Info
- Publication number
- JP2024504927A5 JP2024504927A5 JP2023541723A JP2023541723A JP2024504927A5 JP 2024504927 A5 JP2024504927 A5 JP 2024504927A5 JP 2023541723 A JP2023541723 A JP 2023541723A JP 2023541723 A JP2023541723 A JP 2023541723A JP 2024504927 A5 JP2024504927 A5 JP 2024504927A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- independently
- alkylaminoalkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/071062 | 2021-01-11 | ||
| CN2021071062 | 2021-01-11 | ||
| PCT/US2022/011824 WO2022150707A1 (en) | 2021-01-11 | 2022-01-10 | Fused quadracyclic compounds, compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504927A JP2024504927A (ja) | 2024-02-02 |
| JP2024504927A5 true JP2024504927A5 (cg-RX-API-DMAC7.html) | 2025-01-17 |
Family
ID=82356986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541723A Pending JP2024504927A (ja) | 2021-01-11 | 2022-01-10 | 縮合四環式の化合物、組成物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240140958A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4274833A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024504927A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230145335A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118574834A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022205678A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023013722A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3204167A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304142A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023007992A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150707A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3328394A4 (en) | 2015-07-30 | 2019-03-13 | ModernaTX, Inc. | CONCATEMEE peptide epitope RNAs |
| CN118290358A (zh) * | 2024-03-06 | 2024-07-05 | 江苏医药职业学院 | 一种制备利奈唑胺关键中间体(s)-5-((苄基氨基)甲基)噁唑烷-2-酮的方法 |
| WO2025219950A1 (en) | 2024-04-18 | 2025-10-23 | Astrazeneca Ab | Small molecule cx3cr1 modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10059718B2 (en) * | 2016-01-04 | 2018-08-28 | Tabomedex Biosciences, LLC | Fused quadracyclic compounds, compositions and uses thereof |
-
2022
- 2022-01-10 BR BR112023013722A patent/BR112023013722A2/pt unknown
- 2022-01-10 AU AU2022205678A patent/AU2022205678A1/en active Pending
- 2022-01-10 US US18/270,616 patent/US20240140958A1/en active Pending
- 2022-01-10 JP JP2023541723A patent/JP2024504927A/ja active Pending
- 2022-01-10 CA CA3204167A patent/CA3204167A1/en active Pending
- 2022-01-10 CN CN202280017211.9A patent/CN118574834A/zh active Pending
- 2022-01-10 MX MX2023007992A patent/MX2023007992A/es unknown
- 2022-01-10 WO PCT/US2022/011824 patent/WO2022150707A1/en not_active Ceased
- 2022-01-10 KR KR1020237026555A patent/KR20230145335A/ko active Pending
- 2022-01-10 EP EP22737255.4A patent/EP4274833A4/en active Pending
-
2023
- 2023-06-29 IL IL304142A patent/IL304142A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2320903B1 (en) | THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT | |
| KR102272274B1 (ko) | (ｓ)-3-(4-((4-(모르폴리노메틸)벤질)옥시)-1-옥소이소인돌린-2-일)피페리딘-2,6-디온의 제제 | |
| CA2491243A1 (en) | Viral inhibitors | |
| JP6862404B2 (ja) | 骨髄異形成症候群を治療するためのタンパク質ホスファターゼ２ａ阻害剤 | |
| US6489345B1 (en) | Treatment of diabetes and related pathologies | |
| JP2007536241A (ja) | 糖尿病性腎症の処置のためのａ２ａアデノシンレセプターアゴニスト | |
| EP3222614A2 (en) | Biguanide compound and use thereof | |
| JP2010532383A5 (cg-RX-API-DMAC7.html) | ||
| CN105596320A (zh) | 癌症治疗用选择性ep4受体拮抗物质 | |
| JP2024509981A5 (cg-RX-API-DMAC7.html) | ||
| JP2017508736A (ja) | びまん性大細胞型ｂ細胞リンパ腫の予防および／または治療剤 | |
| RU2008136762A (ru) | Циклические сульфоны как ингибиторы васе | |
| KR20090130079A (ko) | 디스키네시아의 치료 또는 예방제 | |
| CN1461219A (zh) | 非镇静巴比土酸盐化合物用作神经保护剂 | |
| KR100916160B1 (ko) | 약제학적 항암 조성물 | |
| JP2022536043A5 (cg-RX-API-DMAC7.html) | ||
| JP2024509625A5 (cg-RX-API-DMAC7.html) | ||
| TR201802120T4 (en) | A PHARMACEUTICAL COMPOSITION INCLUDING A COMPOUND INCLUDING DIPPEPIDYL PEPTIDASE-IV ACTIVITY AND OTHER ANTIDIABETIC OR ANTIOBETICITY AGENTS AS PROTECTIVE SUBSTANCES FOR PREVENTION AND TREATMENT OF DIABETES OR OBESITY. | |
| CN100479860C (zh) | 包含取代的丙烯酰基偏端霉素衍生物和烷基化剂的抗肿瘤联合疗法 | |
| CN113631164A (zh) | 使用kdm1a抑制剂如化合物伐菲德司他治疗注意缺陷多动症的方法 | |
| AU2015258321B2 (en) | Anti-Tumour Compositions and Methods | |
| EP1299110B1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and antimetabolites | |
| KR20160035061A (ko) | 긴 qt 증후군을 치료하기 위한 화합물 및 방법 | |
| AU2001281867A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents | |
| CN104271140B (zh) | I型和ii型糖尿病的治疗 |